Global Markets
Shingrix sales bounce back post-pandemic for GSK
Global MarketsShingrix sales bounce back post-pandemic for GSKShingrix sales bounce back post-pandemic for GSK
GSK says its vaccine turnover for this quarter benefited from Shingrix’s post-pandemic recovery in the US and Europe.